Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (34)
DNA sequencing with chain-terminating inhibitors
1977 • 69,181 citations
Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
1973 • 12,522 citations
A new technique for the assay of infectivity of human adenovirus 5 DNA
1973 • 9,740 citations
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
1991 • 1,357 citations
Chimeric α 2 -,β 2 -Adrenergic Receptors: Delineation of Domains Involved in Effector Coupling and Ligand Binding Specificity
1988 • 766 citations
cDNA eloping of bovine substance-K receptor through oocyte expression system
1987 • 748 citations
Isolation of a Sialogogic Peptide from Bovine Hypothalamic Tissue and Its Characterization as Substance P
1970 • 689 citations
Tachykinins
1988 • 542 citations
Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function.
1988 • 533 citations
Mammalian Tachykinin Receptors
1991 • 502 citations
Molecular characterization of a functional cDNA for rat substance P receptor
1989 • 463 citations
New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization
1988 • 360 citations
Ligand binding to the β-adrenergic receptor involves its rhodopsin-like core
1987 • 318 citations
Highly selective agonists for substance P receptor subtypes.
1986 • 316 citations
Cloning and expression of a rat neuromedin K receptor cDNA.
1990 • 308 citations
Calculating receptor number from binding experiments using same compound as radioligand and competitor
1989 • 250 citations
Substance P precursor and kininogen: their structures, gene organizations, and regulation
1987 • 241 citations
Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity.
1990 • 237 citations
Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor.
1992 • 190 citations
Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.
1991 • 183 citations
The tachykinins: a family of peptides with a brood of ‘receptors’
1986 • 164 citations
Structural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta 1/beta 2-adrenergic receptors.
1988 • 160 citations
Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors
1990 • 160 citations
Site-directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding.
1991 • 152 citations
Immunomodulation by Tachykinin Neuropeptidesa
1990 • 126 citations
Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
1992 • 121 citations
Demonstration of two distinct tachykinin receptors in rat brain cortex.
1985 • 100 citations
Delineation of structural domains involved in the subtype specificity of tachykinin receptors through chimeric formation of substance P/substance K receptors.
1992 • 97 citations
Nonpeptide antagonists herald new era in tachykinin research
1992 • 85 citations
Selective binding of ligands to beta 1, beta 2 or chimeric beta 1/beta 2-adrenergic receptors involves multiple subsites.
1990 • 76 citations
Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cells.
1991 • 75 citations
Stable expression of high affinity NK1 (substance P) and NK2(neurokinin A) receptors but low affinity NK3 (neurokinin B) receptors in transfected CHO cells
1992 • 34 citations
The extracellular domain of substance P (NK1) receptor comprises part of the ligand binding site
1992 • 16 citations
C-terminal KDEL-modified cystatin C is retained in transfected CHO cells
1990 • 11 citations